Geraldine Henwood is CEO & President at Recro Pharma, Inc. (REPH). They have made 10 open-market trades across 5 companies since 2006, most recently 2022-12-15.
CIK 0001236451
5 open-market purchases totalling $59K since 2006, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BXRX | BUY | 2022-12-15 | 2022-12-19 | $2.55 | $3K | +40.1% | +45.8% | -28.6% |
| BXRX | BUY | 2021-09-22 | 2021-09-23 | $0.59 | $5K | -11.5% | -8.5% | -42.5% |
| BXRX | BUY | 2021-05-07 | 2021-05-10 | $0.83 | $5K | +14.8% | +11.8% | -27.0% |
| REPH | SELL | 2020-04-17 | 2020-04-20 | $8.22 | $658K | +10.4% | -39.6% | -42.6% |
| REPH | SELL | 2019-05-13 | 2019-05-15 | $8.89 | $1.5M | +1.0% | -2.0% | +23.0% |
| REPH | BUY | 2015-06-05 | 2015-06-09 | $8.92 | $40K | -10.2% | -1.5% | -1.5% |
| ALKS | SELL · 10b5-1 | 2014-01-15 | 2014-01-17 | $47.57 | $1.9M | -17.4% | -3.2% | -3.2% |
| ALKS | SELL · 10b5-1 | 2013-08-29 | 2013-08-30 | $31.68 | $634K | -17.4% | -3.2% | -3.2% |
| MAPP | SELL · 10b5-1 | 2013-02-28 | 2013-03-04 | $25.00 | $250K | N/A | N/A | N/A |
| MAPP | SELL · 10b5-1 | 2012-11-23 | 2012-11-27 | $15.00 | $79K | N/A | N/A | N/A |
| ALKS | SELL · 10b5-1 | 2012-08-24 | 2012-08-28 | $17.87 | $715K | -17.4% | -3.2% | -3.2% |
| ALKS | SELL | 2012-02-22 | 2012-02-23 | $17.29 | $830K | -17.4% | -3.2% | -3.2% |
| MAPP | SELL · 10b5-1 | 2010-10-27 | 2010-10-29 | $15.66 | $153K | N/A | N/A | N/A |
| MAPP | SELL | 2010-08-05 | 2010-08-06 | $12.78 | $153K | N/A | N/A | N/A |
| MAPP | SELL | 2009-11-18 | 2009-11-19 | $8.77 | $143K | N/A | N/A | N/A |
| AUXL | BUY | 2006-03-10 | 2006-03-14 | $6.43 | $6K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.